AYALA, FABIO
 Distribuzione geografica
Continente #
EU - Europa 2.746
NA - Nord America 1.833
AS - Asia 1.182
SA - Sud America 213
Continente sconosciuto - Info sul continente non disponibili 65
AF - Africa 15
OC - Oceania 2
Totale 6.056
Nazione #
RU - Federazione Russa 1.979
US - Stati Uniti d'America 1.812
SG - Singapore 500
IE - Irlanda 371
HK - Hong Kong 251
CN - Cina 195
BR - Brasile 182
GB - Regno Unito 136
VN - Vietnam 107
IT - Italia 89
DE - Germania 82
KR - Corea 42
FI - Finlandia 31
JP - Giappone 31
AR - Argentina 15
BD - Bangladesh 13
BE - Belgio 11
SE - Svezia 11
CA - Canada 9
IN - India 7
IQ - Iraq 7
ID - Indonesia 6
EE - Estonia 5
FR - Francia 5
MX - Messico 5
TR - Turchia 5
AZ - Azerbaigian 4
CL - Cile 4
EC - Ecuador 4
ES - Italia 4
RS - Serbia 4
TN - Tunisia 4
UA - Ucraina 4
AT - Austria 3
EU - Europa 3
JM - Giamaica 3
NL - Olanda 3
PK - Pakistan 3
UY - Uruguay 3
ZA - Sudafrica 3
BO - Bolivia 2
HN - Honduras 2
HU - Ungheria 2
JO - Giordania 2
LB - Libano 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
AU - Australia 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
EG - Egitto 1
KE - Kenya 1
KG - Kirghizistan 1
LT - Lituania 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PL - Polonia 1
PT - Portogallo 1
RE - Reunion 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.995
Città #
Moscow 689
Dublin 371
Chandler 321
Santa Clara 252
Hong Kong 249
Singapore 199
San Jose 190
Ashburn 157
Council Bluffs 118
Bremen 59
Cambridge 59
Princeton 59
Roxbury 59
Dallas 56
Beijing 43
Seoul 42
Ho Chi Minh City 39
Milan 33
Hanoi 23
Des Moines 20
Helsinki 18
Wilmington 18
São Paulo 15
Espoo 13
Munich 13
Ann Arbor 11
Brussels 11
Columbus 11
Miano 10
Belo Horizonte 8
Boston 8
Atlanta 7
Los Angeles 7
The Dalles 7
Shanghai 6
Tokyo 6
Rio de Janeiro 5
Biên Hòa 4
Da Nang 4
Falkenstein 4
Guangzhou 4
Haiphong 4
Stockholm 4
Baku 3
Belgrade 3
Changsha 3
Curitiba 3
Frankfurt am Main 3
Hải Dương 3
London 3
Maceió 3
Manchester 3
Montevideo 3
New York 3
Nha Trang 3
Norwalk 3
Perugia 3
Porto Alegre 3
Presidente Prudente 3
Tunis 3
Valparaíso de Goiás 3
Amman 2
Ankara 2
Aracaju 2
Arezzo 2
Bandung 2
Baoding 2
Bexley 2
Brooklyn 2
Campo Grande 2
Can Tho 2
Caratinga 2
Chapecó 2
Charlotte 2
Chicago 2
Cleveland 2
Clifton 2
Duque de Caxias 2
Fazenda Rio Grande 2
Guarulhos 2
Ha Long 2
Hangzhou 2
Istanbul 2
Itapetinga 2
Johannesburg 2
Joinville 2
Kyiv 2
Lấp Vò 2
Minneapolis 2
Monte Grande 2
Montreal 2
Multan 2
Ninh Bình 2
North Bergen 2
Oklahoma City 2
Petrópolis 2
Phoenix 2
Phủ Lý 2
Piscataway 2
Praia Grande 2
Totale 3.368
Nome #
Acrodermatitis continua of Hallopeau respondind to efalizumab therapy 151
'Eczemas' and leptin 147
Abnormal isoaspartyl residues in erythrocyte membranes from psoriasi patients 146
Dermoscopy experts vs dermoscopy non-experts: A comparison between face-to-face diagnosis and telediagnosis for the observation of "pink'' lesions 144
Contact sensitization in the elderly 140
Contact sensitization of children referred to the Dermatology Department of the University Federico II of Naples, Italy: a two-decade years history 136
Chronic hand Eczema: Is IL-36á helpful in diagnosis and classification? 135
Contact sensitization of older patients in an academic department in Naples 131
Patch test results with fragrance markers of the baseline series - Analysis of the European Surveillance System on Contact Allergies (ESSCA) network 2009-2012 131
Climate change and skin 130
Crosstalk between skin inflammation and adipose tissue-derived products: pathogenic evidence linking psoriasis to increased adiposity 129
Educational and motivational support service: a pilot study for mobile-phone-based interventions in patients with psoriasis 127
Pitfalls in patch testing 127
Efficacy and safety of ustekinumab in a group of 22 elderly patients with psoriasis over a 2-year period 125
Differences between the glycosylation patterns of haptoglobin isolated from skin scales and plasma of psoriatic patients 124
Current patch test results with the European baseline series and extensions to it from the 'European Surveillance System on Contact Allergy' network, 2007-2008 124
Development of primary varicella infection during infliximab treatment for psoriasis 124
Effects of adalimumab therapy in adult subjects with moderate-to-severe psoriasis on Th17 pathway 124
Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders 122
Chromatin Assembly Factor-1/p60 overexpression: a potential index of psoriasis severity 122
Effects of climate changes on skin diseases 116
Aquagenic wrinkling of the palms: a case report and literature review 114
Systemic Treatment of Adult Atopic Dermatitis: A Review 110
Psoriasis in elderly and non elderly population: clinical and molecular features 109
Telediagnosis and face-to-face diagnosis reliability for "pink'' lesions 106
Role of single-immunoglobulin interleukin-1 related receptor (SIGIRR) in psoriasis 100
Psoriasis in melanoma patients: a prospective pilot study 97
Pizza Makers? Contact Dermatitis 96
Systemic Treatment of Pediatric Psoriasis: A Review 94
Multiple sclerosis following anti-tumor necrosis factor-alpha therapy for psoriasis: first case in Italy? 93
Psoriasis and melanocytic naevi: does the first confer a protective role against melanocyte progression to naevi? 93
Erythema multiforme-like eruption because of para-phenylenediamine 92
IL-33 and IL-1F9 in allergic contact dermatitis 92
Psoriasis and osteoporosis: data from a Southern Italian population 92
The balance between pro- and anti-inflammatory cytokines is crucial in human allergic contact dermatitis pathogenesis: the role of IL-1 family members 91
Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study 91
The effects of etanercept on replication, proliferation, survival, and apoptosis markers in moderate to severe psoriasis 88
Mechanistic target of rapamycin complex 1 is involved in psoriasis and regulated by anti-TNF-α treatment 88
RAST: Clinical applications 88
European Surveillance System on Contact Allergies (ESSCA): polysensitization, 2009-2014 87
IL-36γ Is Involved in Psoriasis and Allergic Contact Dermatitis 86
IL-33 is secreted by psoriatic keratinocytes and induces pro-inflammatory cytokines via keratinocyte and mast cell activation 86
Psoriatic disease and tuberculosis nowadays 86
IL-26: A new actor in allergic contact dermatitis 84
Understanding the role of haptoglobin in psoriasis: effects of ultraviolet B 84
Visceral Leishmaniasis Infection in a Patient with Psoriasis Treated with Efalizumab 79
Interleukin-33: increasing role in dermatological conditions 78
Instrument-related Skin Disorders in Musicians 78
Psoriasis or "psoriases"? 77
Pathogenesis of Psoriasis: The Role of Pro-Inflammatory Cytokines Produced by Keratinocytes 76
Interleukin-1 family members are enhanced in psoriasis and suppressed by vitamin D and retinoic acid 76
Polymorphic light eruption and innate immunity: the role of interleukin-1 family 75
Psoriasis in Children: a Review 75
Psoriasis and Skin Pain: Instrumental and Biological Evaluations 75
IL-33 effects in psoriasis: The induction of pro-inflammatory cytokines via keratinocyte and mast cell activation 74
IL-33 is regulated by TNF-α in normal and psoriatic skin 74
The European vaseline series in 10 European Countries, 2005/2006 – Results of the European Surveillance System on contact Allergies (ESSCA). Contct Dermatitis 61:31-38, 2009 74
Rational ideation and empiric validation of an innovative digital dermographic tester 72
From the skin to the bone: Pro-osteoclastogenesis inflammatory march 71
Totale 6.056
Categoria #
all - tutte 24.399
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.399


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022317 0 0 0 0 125 5 6 11 9 5 20 136
2022/2023878 66 43 7 106 114 86 0 50 366 5 21 14
2023/2024239 27 7 8 9 105 0 3 0 2 7 23 48
2024/2025999 0 3 2 47 166 152 133 94 200 86 62 54
2025/20263.056 84 65 165 117 275 1.889 176 39 122 51 45 28
2026/2027505 10 64 252 179 0 0 0 0 0 0 0 0
Totale 6.056